July 24, 2024
TOKYO – Kobayashi Pharmaceutical Co.’s Senior Executive Director Satoshi Yamane has been promoted to the post of company president after its chairman and president resigned to take responsibility for health problems caused by the company’s supplements containing “benikoji” red rice mold.
The appointment of Yamane, 64, and the resignations of Chairman Kazumasa Kobayashi, 84, and President Akihiro Kobayashi, 53, were approved at a special meeting of the board of directors on Tuesday morning.
After stepping down as chairman, Kazumasa will become a special adviser. After leaving his post as a director without representative rights, Akihiro will concentrate on dealing with a series of problems and establishing compensation for those harmed by the supplement.
Until now, Kobayashi Pharmaceutical has always been headed by a member of the company’s founding family, so Yamane will be the first non-founder to serve as president of the company.